Trinseo (TSE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
22 Nov, 2025Executive summary
Q1 2025 net loss was $79 million (EPS of -$2.22), with adjusted EBITDA rising to $65 million, up $20 million year-over-year, driven by $26 million in polycarbonate licensing income and restructuring actions.
Free cash flow was negative $119 million, reflecting seasonal working capital build and $25 million in refinancing costs; quarter-end cash was $128 million and total liquidity $421 million.
Major debt refinancing completed, extending nearest maturity to 2028 and improving liquidity, with $416.8 million available at quarter-end.
Transformation strategy continues, with focus on cost reduction, innovation, sustainability, and geographic expansion.
Seven consecutive quarters of year-over-year adjusted EBITDA improvement.
Financial highlights
Q1 2025 net sales were $785 million, down 13% year-over-year due to lower volumes and price declines.
Adjusted EBITDA was $65 million, up from $45 million in Q1 2024, mainly due to $26 million in polycarbonate licensing income and restructuring savings.
Free cash flow was negative $119 million, impacted by working capital build and refinancing costs.
Gross profit increased to $63.8 million from $60.6 million year-over-year.
Interest expense increased to $66.6 million from $63 million year-over-year.
Outlook and guidance
Q2 2025 net loss expected between $61 million and $46 million; adjusted EBITDA guidance of $55 million to $70 million, with breakeven free cash flow expected.
Full-year 2025 guidance withdrawn due to increased economic, tariff, and geopolitical uncertainty.
Company believes liquidity and capital resources are sufficient for at least the next twelve months.
Latest events from Trinseo
- Q4 saw a $251M net loss, 19% sales drop, flat EBITDA, and ongoing restructuring challenges.TSE
Q4 202513 Mar 2026 - Q2 2024 Adjusted EBITDA hit a two-year high, with positive free cash flow expected in H2.TSE
Q2 20242 Feb 2026 - Q3 net loss of $87M, but Adjusted EBITDA rose $25M; liquidity and restructuring improved outlook.TSE
Q3 202415 Jan 2026 - Q4 2024 delivered higher EBITDA and cash flow, but losses persist amid weak demand and restructuring.TSE
Q4 20242 Dec 2025 - Shareholders will vote on directors, compensation, auditor, share issuance, and plan amendments.TSE
Proxy Filing1 Dec 2025 - Shareholders will vote on directors, executive pay, auditor, share issuance, and incentive plan changes.TSE
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and share issuance authority.TSE
Proxy Filing1 Dec 2025 - Q2 2025 net loss and sales decline persist, but cost actions and liquidity measures support outlook.TSE
Q2 202524 Nov 2025 - Q3 2025 net loss widened to $110 million on 14% lower sales, with major restructuring underway.TSE
Q3 202514 Nov 2025